Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Li Kang Biomedical CoROCO:6242 81 Gross Margin % is 67.35% as of Dec. 2025, which is 1% below its 10-year median of 67.94. GuruFocus rates ROCO:6242 with a GF Score™ of 81/100 and a GF Value™ of NT$38.97 (Fairly Valued). The stock has 3 warning signs investors should review. Among 789 Travel & Leisure companies, Li Kang Biomedical Co ranks better than 79.47% on this metric.
ROCO:6242's Gross Margin % is ranked better than 79.47% of 789
companies
in the Travel & Leisure industry
Industry Median: 43.52
vs ROCO:6242: 67.59
Li Kang Biomedical Co had a gross margin of 67.35% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Li Kang Biomedical Co was 0.90% per year.
Li Kang Biomedical Co (ROCO:6242) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Li Kang Biomedical Co had a gross margin of 67.35% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Li Kang Biomedical Co Gross Margin % Related Terms
Li Kang Biomedical Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Li Kang Biomedical Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6242 vs BKNG, ABNB, RCL: Gross Margin % Comparison
For the Travel Services subindustry, Li Kang Biomedical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Li Kang Biomedical Co Gross Margin % vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Li Kang Biomedical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Li Kang Biomedical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Li Kang Biomedical Co (ROCO:6242) has a Gross Margin % of 67.35% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Li Kang Biomedical Co and its competitors. This is near median its historical median of 67.94. Over the past decade, Li Kang Biomedical Co's Gross Margin % has ranged from 56.79 to 68.91. According to the industry distribution chart, Li Kang Biomedical Co ranks #162 out of 789 companies in the Travel & Leisure industry, placing it in the top 20.5%.
Is Li Kang Biomedical Co's Gross Margin % too high?
Li Kang Biomedical Co's current Gross Margin % of 67.35% is near median its 10-year median of 67.94. Over the past 10 years, this metric has ranged from a low of 56.79 to a high of 68.91. The Travel & Leisure industry median Gross Margin % is 43.52. Li Kang Biomedical Co's value of 67.35% is 54.8% above this industry median. Based on the distribution chart, Li Kang Biomedical Co ranks #162 out of 789 companies in the Travel & Leisure industry, which is in the top quartile — a strong position relative to peers. Overall, Li Kang Biomedical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Li Kang Biomedical Co's Gross Margin % compare to BKNG and ABNB?
According to the Travel & Leisure industry distribution chart, Li Kang Biomedical Co ranks #162 out of 789 companies for Gross Margin %. This places Li Kang Biomedical Co in the top 21% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 43.52. Li Kang Biomedical Co's value of 67.35% is 54.8% above this benchmark. Historically, Li Kang Biomedical Co's own Gross Margin % has ranged from 56.79 to 68.91 over the past decade. While the company's 10-year median is 67.94 vs. the industry median of 43.52, Li Kang Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Travel & Leisure company?
The median Gross Margin % among Travel & Leisure companies is 43.52, based on 789 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Li Kang Biomedical Co's current Gross Margin % of 67.35% is 54.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Li Kang Biomedical Co and its competitors. For the Travel & Leisure industry, the median Gross Margin % is 43.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Li Kang Biomedical Co's current Gross Margin % is 67.35%, which is near median its own 10-year median of 67.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Li Kang Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Li Kang Biomedical Co (ROCO:6242) is currently considered Fairly Valued. The stock's GF Value™ is NT$38.97, compared to a current price of NT$35.95 — trading 7.7% below its estimated fair value. The current Gross Margin % is 67.35%, which is near median its 10-year median of 67.94 and 54.8% above the Travel & Leisure industry median of 43.52. Li Kang Biomedical Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Li Kang Biomedical Co (ROCO:6242), the current Gross Margin % is 67.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Li Kang Biomedical Co (ROCO:6242) Overvalued in 2026?
Based on GuruFocus' analysis, Li Kang Biomedical Co stock appears to be undervalued.
The current stock price of NT$35.95 is trading 7.7% below its estimated GF Value™ of NT$38.97.
GuruFocus considers Li Kang Biomedical Co to be Fairly Valued.
Key valuation signals for ROCO:6242:
Gross Margin %: 67.35% (near median its 10-year median of 67.94)
GF Value™: NT$38.97 vs. price of NT$35.95 (7.7% below fair value)
Industry Position: 54.8% above the Travel & Leisure median (#162 of 789)
No single metric tells the full story. See the ROCO:6242 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.
81GF Score
Get the complete analysis for ROCO:6242
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6242 has been successfully added to your 
